The India Cancer Treatment Drugs Market size is projected to grow at a CAGR of around 12.2% during the forecast period, i.e., 2025-30. With estimated 1.39 million cancer cases in 2020, the disease has become a public health concern in India. According to MarkNtel Advisors Study.
India Cancer Treatment Drugs Market Driver:
Numerous Schemes Encouraging Affordable & Effective Cancer Diagnosis &Treatment – Cancer treatment has been one of the main focal areas of the Pradhan Mantri Jan Arogya Yojana in order to protect the beneficiaries from the catastrophic costs of cancer treatment. The delivery of services under the Ayushman Bharat Health and Wellness Centers (AB-HWCs) includes screening for three common malignancies, including oral, breast, and cervical cancers and other common non-communicable diseases.
Along similar lines, The National Pharmaceutical Pricing Authority (NPPA), which is part of the Ministry of Chemicals and Fertilizers, released a list of 390 non-scheduled anti-cancer medications in 2019 with MRP reductions of up to 87%. This action helped 22 lakh cancer patients in the nation and would save consumers about Rs. 800 crores annually. Following a decade of caution and organic growth, Indian pharmaceutical businesses are currently on an acquisition binge. And cancer medications seem to be their primary focus, thus driving the drug industry in the long run.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/india-cancer-treatment-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including(TOC+ List of Table and Figures) : https://www.marknteladvisors.com/research-library/india-cancer-treatment-market.html
India Cancer Treatment Drugs Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2024
-Historical Period: 2020 to 2023
-Forecast Period: 2025 to 2030
- By Treatment Type
- Chemotherapy- Market Size & Forecast 2020-2030, USD Million
- Targeted Therapy- Market Size & Forecast 2020-2030, USD Million
- Immunotherapy- Market Size & Forecast 2020-2030, USD Million
- Hormonal Therapy- Market Size & Forecast 2020-2030, USD Million
- Other Treatment Types- Market Size & Forecast 2020-2030, USD Million
- By Drug Class
- Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
- Alkylating Agents- Market Size & Forecast 2020-2030, USD Million
- Antimetabolites- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Targeted Drugs- Market Size & Forecast 2020-2030, USD Million
- Monoclonal Antibodies- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Hormonal Drugs- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Cytotoxic Drugs- Market Size & Forecast 2020-2030, USD Million
- By Type
- Blood Cancer- Market Size & Forecast 2020-2030, USD Million
- Breast Cancer- Market Size & Forecast 2020-2030, USD Million
- Colorectal Cancer- Market Size & Forecast 2020-2030, USD Million
- Cervical Cancer- Market Size & Forecast 2020-2030, USD Million
- Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
- Gastrointestinal Cancer- Market Size & Forecast 2020-2030, USD Million
- Gynecologic Cancer- Market Size & Forecast 2020-2030, USD Million
- Non-Hodgkin’s Cancer- Market Size & Forecast 2020-2030, USD Million
- Respiratory/ Lung Cancer- Market Size & Forecast 2020-2030, USD Million
- Stomach Cancer- Market Size & Forecast 2020-2030, USD Million
- Other Cancers- Market Size & Forecast 2020-2030, USD Million
- By Dosage Form
- Solid- Market Size & Forecast 2020-2030, USD Million
- Tablets- Market Size & Forecast 2020-2030, USD Million
- Capsules- Market Size & Forecast 2020-2030, USD Million
- Liquid- Market Size & Forecast 2020-2030, USD Million
- Injectable- Market Size & Forecast 2020-2030, USD Million
- Prefilled Syringes- Market Size & Forecast 2020-2030, USD Million
- Others- Market Size & Forecast 2020-2030, USD Million
- Solid- Market Size & Forecast 2020-2030, USD Million
- By End-Users
- Hospitals- Market Size & Forecast 2020-2030, USD Million
- Specialty Clinics- Market Size & Forecast 2020-2030, USD Million
- Cancer and Radiation Therapy Centers- Market Size & Forecast 2020-2030, USD Million
- By Distribution Channel
- Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
- Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
- By Region
- North
- South
- East
- West
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Amgen, Astellas Pharma Inc., AstraZeneca , Bayer, Bristol-Myers Squibb Company, Cipla, F. Hoffmann- La- Roche, Merck KGaA, Natco Pharma, Novartis AG, Pfizer are looking forward to strengthening their market positions.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/india-cancer-treatment-market.html
India Cancer Treatment Drugs Industry Recent Development:
In August 2022, AstraZeneca India, a pharmaceutical company, announced that the Drugs Controller General of India had given the go-ahead to commercialize its medication for breast cancer treatment, Lynparza (Olaparib), as a monotherapy. Lynparza is the first and only approved medicine targeting BRCA (Breast Cancer gene) mutations in early-stage breast cancer.
In June 2022, For the first time in history, a small clinical trial done by Memorial Sloan Kettering Cancer Center discovered that Dostarlimab, a medicine made in a lab that functions as a surrogate for antibodies in the human body, has the potential to be a ‘possible’ cancer cure for one of the most lethal tumors.
Data-Driven Insights Backed by Proven Research
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
